CAS: 863004-48-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
5-Benzyl-2-methyl-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one REF: IN-DA02AKE4CAS: 863004-48-2 | 98% | To inquire | Tue 18 Feb 25 | |
GSK-3β inhibitor 14 REF: TM-T67856CAS: 863004-48-2 | 99.88% | 83.00 €~2,762.00 € | Tue 18 Feb 25 |
5-Benzyl-2-methyl-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
CAS:863004-48-2
Formula:
C17H17NOS
Purity:
98%
Molecular weight:
283.3880
Ref: IN-DA02AKE4
10mg | 163.00 € | ||
25mg | 322.00 € | ||
50mg | 516.00 € | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
GSK-3β inhibitor 14
CAS:863004-48-2
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
Formula:
C17H17NOS
Purity:
99.88%
Color and Shape:
Liquid
Molecular weight:
283.39
- Inhibitors
- Stem Cell and Derivatives
- Stem Cells
- PI3K/Akt/mTOR Signaling
- See more categories
- gsk-3
Ref: TM-T67856
1mg | 83.00 € | ||
5mg | 170.00 € | ||
10mg | 259.00 € | ||
25mg | 439.00 € | ||
50mg | 635.00 € | ||
100mg | 872.00 € | ||
200mg | 1,130.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025